BamSEC and AlphaSense Join Forces
Learn More

Scilex Holding Company

NASDAQ: SCLX    
Share price (12/23/24): $0.46    
Market cap (12/23/24): $87.6 million
Search in Documents
Key Exhibits
External Links

Credit Agreements Filter

EX-10.8
from 8-K 4 pages September 21, 2023 Sorrento Therapeutics, Inc. C/O Scintilla Pharmaceuticals, Inc. 4955 Directors Place San Diego, Ca 92121 Attn: Mohsin Y. Meghji, Chief Restructuring Officer Email: Mmeghji@m3-Partners.com Re: Credit Bid Pay-Off Letter Dear Mr. Meghji
12/34/56
EX-10.9
from 10-Q 58 pages Junior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement by and Among Sorrento Therapeutics, Inc. Scintilla Pharmaceuticals, Inc. as Borrowers, and Scilex Holding Company, as Lender Dated as of July 28, 2023
12/34/56
EX-10.2
from 8-K 15 pages Intercreditor and Subordination Agreement
12/34/56
EX-10.1
from 8-K 16 pages July 5, 2023 Sorrento Therapeutics, Inc. Scintilla Pharmaceuticals, Inc. Debtor-In-Possession Term Loan Facility Summary of Terms and Conditions
12/34/56
EX-10.1
from 8-K 79 pages Credit and Security Agreement Between Scilex Pharmaceuticals Inc. as the Borrower and Ecapital Healthcare Corp. as the Lender Dated as of June 27, 2023 Credit and Security Agreement
12/34/56
EX-10.61
from S-4/A 2 pages Scilex Holding Company 960 San Antonio Road Palo Alto, Ca 94303 Attn: Jaisim Shah Its: CEO Re: Certain Loan Commitments
12/34/56
EX-10.56
from S-4/A 69 pages Credit and Security Agreement Between Scilex Pharmaceuticals Inc. as the Borrower and Cnh Finance Fund I, L.P. as the Lender Dated as of December 14, 2020 Credit and Security Agreement
12/34/56
EX-10.53
from S-4/A 15 pages Contribution and Loan Agreement
12/34/56
EX-10.51
from S-4/A 6 pages ***Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Information That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[...***...]”) in This Exhibit. *** Sorrento Therapeutics, Inc. 4955 Directors Place San Diego, California 92121 Irrevocable Standby Letter of Credit
12/34/56
EX-10.48
from S-4/A 12 pages Consent Under and Amendment No. 3 to Indenture and Letter of Credit
12/34/56
EX-10.47
from S-4/A 9 pages ***Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Information That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[...***...]”) in This Exhibit. *** Omnibus Amendment No. 2 to Indenture and Letter of Credit
12/34/56
EX-10.46
from S-4/A 11 pages Omnibus Amendment No. 1 to Indenture and Letter of Credit
12/34/56